🎥 WATCH: Alexander N. Shoushtari, MD, of @mskcancercenter.bsky.social, discusses the current role, benefits, and limitations of monitoring ctDNA in metastatic uveal melanoma. #melsm #oncology

Full video ➡️: www.onclive.com/view/dr-shou...

Adjuvant avelumab numerically improved RFS vs placebo, without reaching statistical significance, in patients with high-risk stage III Merkel cell carcinoma, according to Shailender Bhatia, MD, of @fredhutch.org. #melsm #oncology

More insights ➡️: www.onclive.com/view/adjuvan...

🔬"The fact that we have patients out 5 years corroborates that this could have a big impact for this disease," said Udai S. Kammula, MD, FACS, of @upmchillmancc.bsky.social on TIL therapy outcomes in metastatic uveal melanoma.

Read more here 🤔: www.onclive.com/view/tumor-r...

#melsm #oncology